Logo image of CNR

CORE NATURAL RESOURCES INC (CNR) Stock Fundamental Analysis

USA - NYSE:CNR - US2189371006 - Common Stock

97.75 USD
+0.04 (+0.04%)
Last: 10/9/2025, 9:02:36 PM
97.75 USD
0 (0%)
After Hours: 10/9/2025, 9:02:36 PM
Fundamental Rating

5

CNR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. CNR has an average financial health and profitability rating. CNR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CNR had positive earnings in the past year.
In the past year CNR had a positive cash flow from operations.
CNR had positive earnings in 4 of the past 5 years.
CNR had a positive operating cash flow in each of the past 5 years.
CNR Yearly Net Income VS EBIT VS OCF VS FCFCNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.33%, CNR is doing worse than 66.82% of the companies in the same industry.
With a Return On Equity value of 0.55%, CNR is not doing good in the industry: 65.88% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 1.90%, CNR is not doing good in the industry: 71.09% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for CNR is above the industry average of 21.57%.
The last Return On Invested Capital (1.90%) for CNR is well below the 3 year average (24.39%), which needs to be investigated, but indicates that CNR had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROIC 1.9%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
CNR Yearly ROA, ROE, ROICCNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

With a Profit Margin value of 0.63%, CNR is not doing good in the industry: 63.98% of the companies in the same industry are doing better.
CNR's Profit Margin has improved in the last couple of years.
CNR's Operating Margin of 3.73% is on the low side compared to the rest of the industry. CNR is outperformed by 68.72% of its industry peers.
In the last couple of years the Operating Margin of CNR has grown nicely.
The Gross Margin of CNR (20.38%) is worse than 65.88% of its industry peers.
In the last couple of years the Gross Margin of CNR has declined.
Industry RankSector Rank
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
CNR Yearly Profit, Operating, Gross MarginsCNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

CNR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CNR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CNR has more shares outstanding
CNR has a better debt/assets ratio than last year.
CNR Yearly Shares OutstandingCNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNR Yearly Total Debt VS Total AssetsCNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CNR has an Altman-Z score of 2.14. This is not the best score and indicates that CNR is in the grey zone with still only limited risk for bankruptcy at the moment.
CNR has a Altman-Z score of 2.14. This is in the better half of the industry: CNR outperforms 67.77% of its industry peers.
The Debt to FCF ratio of CNR is 2.46, which is a good value as it means it would take CNR, 2.46 years of fcf income to pay off all of its debts.
CNR has a Debt to FCF ratio of 2.46. This is in the better half of the industry: CNR outperforms 79.15% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that CNR is not too dependend on debt financing.
The Debt to Equity ratio of CNR (0.09) is better than 77.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Altman-Z 2.14
ROIC/WACC0.22
WACC8.82%
CNR Yearly LT Debt VS Equity VS FCFCNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CNR has a Current Ratio of 1.78. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.78, CNR is doing good in the industry, outperforming 72.99% of the companies in the same industry.
CNR has a Quick Ratio of 1.25. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.25, CNR is in the better half of the industry, outperforming 63.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.25
CNR Yearly Current Assets VS Current LiabilitesCNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

The earnings per share for CNR have decreased strongly by -74.91% in the last year.
CNR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.60% yearly.
Looking at the last year, CNR shows a very strong growth in Revenue. The Revenue has grown by 45.25%.
CNR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.16% yearly.
EPS 1Y (TTM)-74.91%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-135.71%
Revenue 1Y (TTM)45.25%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%119.98%

3.2 Future

The Earnings Per Share is expected to grow by 9.84% on average over the next years. This is quite good.
Based on estimates for the next years, CNR will show a very strong growth in Revenue. The Revenue will grow by 25.25% on average per year.
EPS Next Y-112.17%
EPS Next 2Y5.83%
EPS Next 3Y4.41%
EPS Next 5Y9.84%
Revenue Next Year77.91%
Revenue Next 2Y39.26%
Revenue Next 3Y25.25%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNR Yearly Revenue VS EstimatesCNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CNR Yearly EPS VS EstimatesCNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.83, CNR can be considered very expensive at the moment.
CNR's Price/Earnings ratio is a bit more expensive when compared to the industry. CNR is more expensive than 60.19% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.70, CNR is valued at the same level.
Based on the Price/Forward Earnings ratio of 9.08, the valuation of CNR can be described as reasonable.
CNR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CNR is cheaper than 76.78% of the companies in the same industry.
CNR is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.83
Fwd PE 9.08
CNR Price Earnings VS Forward Price EarningsCNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CNR's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as CNR.
Industry RankSector Rank
P/FCF 31.66
EV/EBITDA 9.54
CNR Per share dataCNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.28
EPS Next 2Y5.83%
EPS Next 3Y4.41%

0

5. Dividend

5.1 Amount

CNR has a yearly dividend return of 0.64%, which is pretty low.
Compared to an average industry Dividend Yield of 6.07, CNR is paying slightly less dividend.
With a Dividend Yield of 0.64, CNR pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 0.64%

5.2 History

CNR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNR Yearly Dividends per shareCNR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

148.79% of the earnings are spent on dividend by CNR. This is not a sustainable payout ratio.
DP148.79%
EPS Next 2Y5.83%
EPS Next 3Y4.41%
CNR Yearly Income VS Free CF VS DividendCNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
CNR Dividend Payout.CNR Dividend Payout, showing the Payout Ratio.CNR Dividend Payout.PayoutRetained Earnings

CORE NATURAL RESOURCES INC

NYSE:CNR (10/9/2025, 9:02:36 PM)

After market: 97.75 0 (0%)

97.75

+0.04 (+0.04%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners94.28%
Inst Owner Change0%
Ins Owners1.87%
Ins Owner Change-5.77%
Market Cap5.03B
Analysts77.78
Price Target99.35 (1.64%)
Short Float %4.97%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield 0.64%
Yearly Dividend0.53
Dividend Growth(5Y)N/A
DP148.79%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-158.97%
Min EPS beat(2)-207.45%
Max EPS beat(2)-110.49%
EPS beat(4)1
Avg EPS beat(4)-94.7%
Min EPS beat(4)-207.45%
Max EPS beat(4)0.73%
EPS beat(8)4
Avg EPS beat(8)-35.57%
EPS beat(12)8
Avg EPS beat(12)-12.67%
EPS beat(16)10
Avg EPS beat(16)-41.07%
Revenue beat(2)2
Avg Revenue beat(2)7.34%
Min Revenue beat(2)2.77%
Max Revenue beat(2)11.91%
Revenue beat(4)3
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-24.65%
Max Revenue beat(4)11.91%
Revenue beat(8)6
Avg Revenue beat(8)1.77%
Revenue beat(12)10
Avg Revenue beat(12)5.56%
Revenue beat(16)13
Avg Revenue beat(16)9.28%
PT rev (1m)2.8%
PT rev (3m)4.73%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)-106.58%
EPS NY rev (1m)-18.51%
EPS NY rev (3m)-111.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.28%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE 28.83
Fwd PE 9.08
P/S 1.53
P/FCF 31.66
P/OCF 12.8
P/B 1.34
P/tB 1.34
EV/EBITDA 9.54
EPS(TTM)3.39
EY3.47%
EPS(NY)10.76
Fwd EY11.01%
FCF(TTM)3.09
FCFY3.16%
OCF(TTM)7.64
OCFY7.81%
SpS63.72
BVpS73.2
TBVpS73.2
PEG (NY)N/A
PEG (5Y)1.28
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROCE 2.22%
ROIC 1.9%
ROICexc 2.06%
ROICexgc 2.06%
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
FCFM 4.85%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
ROICexc(3y)28.23%
ROICexc(5y)18.22%
ROICexgc(3y)28.23%
ROICexgc(5y)N/A
ROCE(3y)28.54%
ROCE(5y)18.52%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y35.93%
ROICexc growth 5Y15.67%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Debt/EBITDA 0.64
Cap/Depr 58.19%
Cap/Sales 7.14%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 770.76%
Current Ratio 1.78
Quick Ratio 1.25
Altman-Z 2.14
F-Score6
WACC8.82%
ROIC/WACC0.22
Cap/Depr(3y)74.91%
Cap/Depr(5y)64.93%
Cap/Sales(3y)7.37%
Cap/Sales(5y)8.18%
Profit Quality(3y)104.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.91%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-135.71%
EPS Next Y-112.17%
EPS Next 2Y5.83%
EPS Next 3Y4.41%
EPS Next 5Y9.84%
Revenue 1Y (TTM)45.25%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%119.98%
Revenue Next Year77.91%
Revenue Next 2Y39.26%
Revenue Next 3Y25.25%
Revenue Next 5YN/A
EBIT growth 1Y-74.63%
EBIT growth 3Y34.19%
EBIT growth 5Y12.15%
EBIT Next Year38.6%
EBIT Next 3Y35.04%
EBIT Next 5Y24.71%
FCF growth 1Y-73.9%
FCF growth 3Y19.97%
FCF growth 5Y31.85%
OCF growth 1Y-49.63%
OCF growth 3Y15.95%
OCF growth 5Y14.26%